Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

PRU · Q4 2025 Earnings

Prudential Financial

Reported April 14, 2026

30-second summary

Prudential disclosed that misconduct at Prudential of Japan (POJ) triggered a 90-day Life Planner sales suspension, with management quantifying a $300–350M pre-tax adjusted operating income hit to 2026 and conceding the 5–8% three-year EPS growth target may only reach the low end by 2027. Reported Q4 after-tax AOI of $1,168M and AOI EPS of $3.30 include a $107M / $0.30 per share one-time charge (primarily severance); ex-charge EPS was $3.60, up 22% YoY, and U.S. Businesses pre-tax AOI rose 22% — so underlying Q4 was actually strong on an operating basis. FY revenue dropped 15% largely reflecting lumpy PRT premium recognition ($3.7B in FY25 vs. $16.4B in FY24) rather than underlying business deterioration. The 90-day suspension is explicitly not a hard endpoint — management said twice it "could result in an extension" — making the Japan disclosure and the softened 2027 EPS framing, not the Q4 operating print, the defensive elements of this report.

Headline numbers

EPS

Q4 FY2025

$3.30

Revenue

Q4 FY2025

$14.52B

-15.0% YoY

Key financials

Q4 FY2025

Metric	Q4 FY2025	YoY	Q3 FY2025	QoQ
Revenue	$14.52B	-15.0%	$16.24B	-10.6%
EPS	$3.30	—	$4.26	-22.5%

Guidance

No FY2025 actuals guidance comparison available; company disclosed significant 2026 headwinds ($300-350M POJ impact) while reaffirming long-term targets and introducing new margin expansion and VA runoff forecasts.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

New guidance

Metric	Period	Guide	YoY
2026 POJ issue pre-tax adjusted operating income impact	FY 2026	$300 to $350 million	—
2026 PGIM margin expansion	FY 2026	200+ basis points	—
2026 VA legacy block annual runoff impact	FY 2026	$100 to $150 million pre-tax adjusted operating income	—
2026 intermediate EPS growth target (2024-2027)	FY 2026	5% to 8% (may be at low end due to POJ impact)	—

Segment performance

Q4 FY2025

Segment	Q4 FY2025	YoY
PGIM	$1.108B	+3.0%
U.S. Businesses	$8.947B	-24.0%
U.S. Retirement	$4.987B	-36.0%
U.S. Group Insurance	$1.645B	+5.0%
U.S. Individual Life	$1.124B	+3.0%

Capital & returns

Q4 FY2025

Segment	Q4 FY2025
Operating Return on Average Equity (OROAE)	13.3%
Return on Average Equity (ROAE)	11.2%
Adjusted Book Value Per Share	$100.17
Total Capital Returned to Shareholders	$730 million

Other KPIs

Q4 FY2025

Segment	Q4 FY2025
Adjusted Operating Income (AOI) Before Taxes	$1,505 million
After-tax Adjusted Operating Income	$1,168 million
Total Assets Under Management and Administration	$1,804.2 billion
PGIM Assets Under Management	$1,466.1 billion

Management tone

Narrative arc: Q3 2025 PGIM restructuring → Q4 2025 Japan misconduct crisis.

From Japan as 40-year franchise to Japan as remediation project. In Q3, Japan was discussed in terms of surrender stabilization and a 180–200% ESR ratio supporting the AA rating. This quarter, CEO Andy Sullivan framed it differently: "While there are financial implications to the sales suspension, we believe that this is the prudent path forward in addressing the misconduct and positioning our business in Japan to rebuild customer trust." The pivot from celebrating the Life Planner channel to suspending it — with no committed resumption date — is the largest single tone shift PRU has made in years.

From "we will hit the 5–8% EPS range" to "we may hit the low end, or miss it." In Q3 the 5–8% intermediate target was reaffirmed cleanly. This quarter CFO Yanela Frias said the POJ impact "could bring us to the low end of this range by the end of 2027" and added the explicit caveat: "To the extent that the magnitude and or duration of the POJ issue is different than we currently anticipate, we may not hit the low end of the EPS range." That second sentence is the disclosure that matters — the floor is now negotiable.

From "90-day suspension" to "90-day floor." Management said twice on the call that the 90-day window is not a ceiling: "we will not resume distribution through the Life Planner channel until we are comfortable that our internal compliance and oversight environment supports doing so. This could result in an extension of the 90-day period." Repetition signals deliberate expectation-setting — investors who model a clean Q2 2026 sales resumption are being warned not to.

From PGIM reorganization narrative to PGIM headwind narrative. Last quarter's story was that consolidating six units into one would accelerate the path to a 25–30% margin. This quarter the framing shifted: management acknowledged active-to-passive outflows are "weighing on PGM's organic growth and earnings momentum," and Q4 PGIM income was down slightly despite market tailwinds. The 200+ bps 2026 margin expansion guide (reaffirmed from last quarter) remains the structural response, but the gap between organic growth pressure and margin engineering is now explicit.

Capital deployment defended firmly under questioning. Asked directly by Joel Hurwitz whether POJ losses and Japan macro pressure would force a pullback, Frias was unambiguous: PRU does "not expect an impact to our capital deployment plans or our shareholder distribution," citing diversified cash flow sources across POJ, Gibraltar, PGFL, Prudential Insurance, and Gibraltar Re. That said, the Board authorized "up to $1 billion" of buybacks for 2026 — matching the 2025 pace, not raising it.

Recurring themes management leaned on this quarter:

Japan misconduct remediation and trust restorationEarnings impact from 90-day sales suspension ($300-350M in 2026)Active-to-passive industry headwinds pressuring PGM organic growthYen volatility and FX-sensitive surrenders in Japan blockU.S. retirement strategies momentum offsetting international headwindsOperational restructuring for discipline and accountability

Risks management surfaced:

90-day sales suspension could extend beyond current timeline if compliance environment not satisfiedGenesyn (active equity platform) experiencing systemic outflows from active-to-passive shiftJapan business surrender activity may remain elevated; FX and rate sensitivities unpredictablePotential regulatory fines or additional actions beyond voluntary remediation measuresGibraltar Life review ongoing with potential recruiting headwindsVariable annuity runoff headwind continuing ($100-150M annually pre-market impacts)

Answers to last quarter's watch list

PGIM margin trajectory toward 25%–30%. Management reaffirmed 200+ bps of margin expansion for 2026, explicitly framed as "accelerating the path towards our 25 to 30% margin target." Frias noted "as we noted last quarter" — this is a continuation of prior guidance, not a new disclosure. It also comes alongside acknowledged organic growth pressure from active-to-passive outflows, so the margin path is engineered rather than flow-driven. Status: Continue monitoring (on the underlying flow quality).

VA runoff drag versus ~$100M FY2025 figure. Management now guides $100–150M of pre-tax AOI runoff for 2026 — a wider band, biased higher than the $100M reference from Q3. U.S. Retirement FY revenue down 36% confirms the drag is not abating.

Resolved negatively

PRT market size realization. Not specifically addressed in the materials available for this brief.

Continue monitoring

RILA share trajectory. Not specifically called out in the Q4 disclosures.

Continue monitoring

Japan surrender activity and stabilization. The Q3 "signs of stabilization" narrative is gone; the issue has been overtaken by the POJ misconduct disclosure and Life Planner sales suspension. FX-sensitive surrenders remain a risk per management. Status: Resolved negatively — the Japan story is now defined by remediation, not stabilization.

Concrete cost or revenue synergy targets for the PGIM reorganization. Answered indirectly via the reaffirmed 200+ bps margin expansion target. No standalone reorganization synergy number disclosed.

Continue monitoring

What to watch into next quarter

Whether the Life Planner sales suspension extends beyond 90 days. Management has explicitly built in this optionality; any extension or revised timeline materially changes the 2026 AOI headwind beyond the current $300–350M range.

Realized POJ impact run-rate in Q1 2026 versus a $75–88M naive quarterly average. Per Frias's component breakdown, the impact is front-loaded in the suspension window (H1 2026), not evenly spread across the year — Q1 should print materially heavier than a simple divide-by-four implies.

Whether Gibraltar Life is dragged into the remediation. Sullivan confirmed an ongoing Gibraltar review concluding "a few months from now," with modest life consultant recruiting pressure already visible — a second-leg disclosure here would widen the Japan damage materially.

PGIM organic flows in Q1 2026. The 200+ bps margin target is achievable on cost discipline alone; the question is whether net flows turn positive, particularly in the Jennison fundamental active equity platform flagged as experiencing "systemic outflows."

Capital return cadence. Q4 capital return was $730M total ($480M dividends + $250M buybacks). The 2026 buyback authorization of "up to $1B" matches the 2025 pace — watch whether the $250M quarterly buyback pace holds as POJ remediation costs are absorbed.

Any regulatory action beyond the voluntary suspension — fines, consent orders, or expanded remediation — which would convert the current $300–350M estimate into a floor rather than a midpoint.

Sources

Prudential Financial Q4 FY2025 Quarterly Financial Supplement / 8-K (SEC filing): https://www.sec.gov/Archives/edgar/data/1137774/000113777426000087/exhibit991-4q25qfsrestatem.htm
Prudential Financial Q4 FY2025 earnings call prepared remarks and Q&A (Andy Sullivan, CEO; Yanela Frias, CFO).
Prudential Financial Q3 FY2025 prior coverage (tapebrief).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.